SCOR continues to implement its strategic plan “Optimal Dynamics” with the creation of a new business unit dedicated to the “Alternative Solutions” initiative within its SCOR Global P&C division.
SCOR continues to implement its strategic plan “Optimal Dynamics” with the creation of a new business unit dedicated to the “Alternative Solutions” initiative within its SCOR Global P&C division.
SCOR's first quarter of 2014 results.
All the proposed resolutions were adopted by SCOR’s shareholders by a very large majority, including payment of a dividend of EUR 1.30 per share for the 2013 financial year.
SCOR Global Life's embedded value results of 2013.
SCOR delivers a strong performance for the first quarter 2014 with a net income of EUR 135 million, up 21.6%
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets.
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
Availability of the documents relating to the 2014 combined general shareholders' meeting.
Founded in 1921 by a cooperative of French university professors, PUF is a publishing house specialising in the publication of books, journals, university manuals, essays and monographs in the field of humanities and
Pagination